Taken together, the data are consistent with a model in which tumor-dependent remodeling of the fibronectin in the ECM promotes inflammation through the activation of TLR4/NF-κB signaling in NSCLC. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.